CellTrans Inc.
Quick facts
Phase 3 pipeline
- Islets of Langerhans transplantation · Endocrinology / Diabetes
Islet transplantation restores functional insulin-producing beta cells to the pancreas, enabling endogenous insulin secretion and glucose homeostasis in patients with type 1 diabetes.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about CellTrans Inc.
What is CellTrans Inc.'s pipeline?
CellTrans Inc. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Islets of Langerhans transplantation.
Related
- Sector hub: All tracked pharma companies